Position in ELAN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$303,317
-$1,215,208 QoQ
Shares Held
12,325
-80.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#330
of 518 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Arkadios Wealth Advisors holds $9,536,496 across 8 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRX |
Amneal Pharmaceuticals, Inc.
|
329,652 | $5,706,275 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
11,732 | $971,174 | |
| 3 | HLN |
Haleon plc
|
79,806 | $744,589 | |
| 4 | ZTS |
Zoetis Inc.
|
9,953 | $715,221 | |
| 5 | VTRS |
Viatris Inc
|
35,208 | $559,102 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
15,265 | $529,236 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
12,325 | $303,317 | |
| 8 | CTOR |
Citius Oncology, Inc.
|
11,666 | $7,582 |
All Filings in ELAN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $303,317 | 12,325 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,518,525 | 63,457 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,196,402 | 52,868 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,051,629 | 52,216 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $696,606 | 48,782 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $254,919 | 24,278 | Shares | Sole | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||